Levodopa-Carbidopa Intestinal Gel Titration with and without a Nasojejunal Titration Period in Advanced Parkinson's Disease Patients

被引：0
|
作者：
Lew, Mark F.
Fung, Victor S. C.
Robieson, Weining Z.
Dubow, Jordan
Chatamra, Krai
Benesh, Janet
机构：
来源：
ANNALS OF NEUROLOGY | 2014年 / 76卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
S421
引用
收藏
页码：S43 / S43
页数：1
相关论文
共 50 条
  • [21] Telemedicine facilitates efficient and safe home titration of levodopa/carbidopa intestinal gel (LCIG) in patients with advanced Parkinson's disease
    Willows, T.
    Dizdar, N.
    Nyholm, D.
    Widner, H.
    Grenholm, P.
    Schmiauke, U.
    Urbom, A.
    Groth, K.
    Larsson, J.
    Permert, J.
    Kjellander, S.
    MOVEMENT DISORDERS, 2016, 31 : S625 - S625
  • [22] Continuous infusion of levodopa-carbidopa intestinal gel in Parkinson's disease
    Guthikonda, Lalitha N.
    Lyons, Kelly E.
    Pahwa, Rajesh
    JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH, 2014, 3 (04) : 331 - 333
  • [23] Efficacy of levodopa-carbidopa intestinal GEL infusion on advanced Parkinson's disease patients at our hospital
    Sakata, M.
    Hiwatani, Y.
    Matsumoto, T.
    Minamino, M.
    Hironishi, M.
    Ito, H.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2017, 381 : 728 - 728
  • [24] Stable levodopa plasma levels with jejunal infusion of levodopa-carbidopa intestinal gel in advanced Parkinson's disease patients
    Nyholm, D.
    Odin, P.
    Johansson, A.
    Chatamra, K.
    Locke, C.
    Freeman, S.
    Dutta, S.
    Othman, A. A.
    MOVEMENT DISORDERS, 2012, 27 : S131 - S131
  • [25] Comment on: “Levodopa-Carbidopa Intestinal Gel in Patients with Parkinson’s Disease: A Systematic Review”
    Andrew T. Lambarth
    CNS Drugs, 2016, 30 : 1007 - 1008
  • [26] Comment on: "Levodopa-Carbidopa Intestinal Gel in Patients with Parkinson's Disease: A Systematic Review"
    Lambarth, Andrew T.
    CNS DRUGS, 2016, 30 (10) : 1007 - 1008
  • [27] Efficacy of Levodopa-Carbidopa Intestinal Gel Versus Oral Levodopa-Carbidopa in Advanced Parkinson's: Sensitivity and Responder Analyses
    Boyd, James T.
    Fernandez, Hubert H.
    Slevin, John T.
    Espay, Alberto J.
    Standaert, David G.
    Pritchett, Yili
    Zhang, Wuyan
    Chatamra, Krai
    Widnell, Katherine L.
    Benesh, Janet
    ANNALS OF NEUROLOGY, 2013, 74 : S44 - S44
  • [28] Dopamine dysregulation syndrome in Parkinson's disease patients on levodopa-carbidopa intestinal gel
    Solla, Paolo
    Cannas, Antonino
    Marrosu, Maria Giovanna
    Marrosu, Francesco
    PARKINSONISM & RELATED DISORDERS, 2015, 21 (11) : 1383 - 1384
  • [29] The Cost Effectiveness of Levodopa-Carbidopa Intestinal Gel in the Treatment of Advanced Parkinson’s Disease in England
    K. Ray Chaudhuri
    A. Simon Pickard
    Ali Alobaidi
    Yash J. Jalundhwala
    Prasanna L. Kandukuri
    Yanjun Bao
    Julia Sus
    Glynn Jones
    Christian Ridley
    Julia Oddsdottir
    Seyavash Najle-Rahim
    Matthew Madin-Warburton
    Weiwei Xu
    Anette Schrag
    PharmacoEconomics, 2022, 40 : 559 - 574
  • [30] Effects of levodopa-carbidopa intestinal gel on non-motor symptoms and safety of outpatient titration: A new phase 3 study in patients with advanced Parkinson's disease
    Standaert, D. G.
    Slevin, J. T.
    Hall, C.
    Dubow, J.
    Eaton, S.
    Chatamra, K.
    Benesh, J. A.
    MOVEMENT DISORDERS, 2015, 30 : S128 - S129
12345